CN202027990U - Venous retention needle sleeve element with pipe sealing device - Google Patents
Venous retention needle sleeve element with pipe sealing device Download PDFInfo
- Publication number
- CN202027990U CN202027990U CN2011200243518U CN201120024351U CN202027990U CN 202027990 U CN202027990 U CN 202027990U CN 2011200243518 U CN2011200243518 U CN 2011200243518U CN 201120024351 U CN201120024351 U CN 201120024351U CN 202027990 U CN202027990 U CN 202027990U
- Authority
- CN
- China
- Prior art keywords
- pipe
- sealing device
- pipe sealing
- sealing
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a venous retention needle sleeve element with a pipe sealing device, which comprises a sleeve pipe, a transparent three-way valve and a transfusion joint, wherein the sleeve pipe is pricked into the vein through being guided by a puncture needle, the transparent three-way valve is connected with the back end of the sleeve pipe and is provided with a built-in insulation sealing plug, the transfusion joint is used for connecting a transfusion pipeline or a blooding pipeline, the transparent three-way valve is connected with the transfusion joint through a lengthening pipe, the transfusion joint is sealed through a sealing end cap, a double-cavity joint is formed at one end of the transparent three-way valve, which is connected with the lengthening pipe, one end of the double-cavity joint is connected with the lengthening pipe, the other end of the double-cavity joint is connected with the pipe sealing device, the pipe sealing device comprises a liquid storage bag and a rolling wheel, the liquid storage bag is arranged on a support frame, and the rolling wheel is arranged between the two side walls of the support frame and is used for forwards pushing liquid in the liquid storage bag. The venous retention needle sleeve element with the pipe sealing device can ensure that a pipe cavity of a retention needle is filled with pipe sealing liquid, the pipe sealing liquid in the pipe sealing device adopts hirudin diluent, a good anticoagulation effect is realized, and in addition, the detection of anticoagulation factors in the blood can not be influenced.
Description
Technical field
This utility model belongs to technical field of medical instruments, particularly relates to a kind of venous detaining needle external member with pipe sealing device.
Background technology
In recent years, develop rapidly along with medical science applied, the venous detaining needle that can alleviate patient's repeated localised puncture misery has been widely used among the patient of critical patient's rescue transfusion, intravenous hyperalimentation and vein batch applications antibiotic or other medicines.Venous detaining needle comprises puncture needle and sleeve pipe.After the puncture needle band sleeve pipe and penetrated patient's vein, extract puncture needle, sleeve pipe stays in the body, and the outer end connects infusion set or blood-taking device again.Venous detaining needle not only can be used for conventional venous transfusion, and can be used for repeatedly taking a blood sample discontinuously, and the misery of both having avoided repeated localised puncture to cause to the patient has been protected patient's vein again, can also improve nurse's work efficiency simultaneously.
Because the sleeve pipe of venous detaining needle needs the long period to stay in the human vein, after each transfusion is finished, cause tube chamber to stop up for preventing that blood from refluxing to condense, all need to carry out tube sealing.Usually use common syringe that tube-sealing solution is injected now and carry out tube sealing in the remaining needle tube chamber." practical Chinese medicine magazine " 2010 the 26th 1 phases of volume, put down in writing in " application of venous detaining needle and nursing " literary composition that Zhang Jianrong, the Hou Sifang in the hospital of traditional Chinese hospital, Ninghe County, Tianjin delivers, the tube sealing maneuver is an important ring, usually adopt slowly injection malleation sealed-tube method, be that the limit is slowly injected the limit and withdrawed from syringe needle, guarantee that needle tip keeps malleation, avoid backflow of blood to the blood vessel pin, cause the blood coagulation plugging.Above-mentioned blood vessel pin promptly refers to the sleeve pipe of remaining needle.But this use ordinary syringe is carried out pipe sealing method, and to be the nurse push the dosage of tube-sealing solution according to oneself experience decision, the dosage control that does not have strict standard, be difficult to guarantee all to be full of tube-sealing solution in each remaining needle tube chamber, especially the sleeve pipe front end stretches into human body parts and is difficult to observe, if tube sealing does not thoroughly make backflow of blood to the sleeve pipe front end, caused the blood coagulation plugging not to be found again, agglomerative clot is poured in the human vein by liquid when infusing once more, can cause the generation of thrombosis.
" Chinese general family medicine " March in 2010, the 8th volume the 3rd phase 395-396 page or leaf was put down in writing heparin sodium diluent and normal saline that present clinical main tube-sealing solution commonly used is a variable concentrations in " effect of two kinds of tube sealing methods of venous detaining needle relatively ".Normal saline can prevent blood coagulation with the effect of keeping extracellular osmotic pressure, blood volume and water-electrolyte balance, blood circulation, and little to vascular stimulation, its malleation tube sealing is safe and reliable, and clinical practice is extensive than the heparin in sealing method.But the normal saline tube sealing time is shorter, and conventional normal saline needs 3-5 hour tube sealing once, has increased nurse's workload, also bothers patient and has a rest.And the normal saline tube sealing easily causes phlebitis, because normal saline using dosage once probably needs 10-30ml, and generally can only tube sealing 3-5h, the nursing staff need be through normal saline flushing pipeline commonly used, flushing line need puncture as the calparine cap of sealing end cap, because calparine cap just is easy to by germ contamination through repeatedly puncturing, flows into human body by transfusion and cause symptoms such as phlebitis.Part calparine cap poor quality is arranged in addition, and repeatedly puncture is passed through infusion pipeline with trickle medical grade rubber chip easily, directly enters human vas and causes bigger harm.
Therefore, clinically also often the result of use heparin sodium diluent that is better than normal saline carry out tube sealing.Heparin is a kind of acid mucopolysaccharide, all has stronger anticoagulation when using in vivo and in vitro, the dilution back is widely used in clinical as the remaining needle tube-sealing solution, use a small amount of Calciparine/sodium salt water sealing (sealing water) pipe, phlebitic incidence rate is starkly lower than the normal saline tube sealing, and tube sealing effect retention time is longer than the normal saline tube sealing.But the heparin sodium tube sealing still has inevitable shortcoming, because heparin sodium has certain side effect to cause anticoagulant easily, easily causes bleeding, dosage is difficult for shortcomings such as grasp, so for have, the patient of disturbances of blood coagulation, Ying Shenyong in order to avoid increase the weight of the state of an illness, adverse consequences occurs.The remaining needle operation of can drawing blood in addition avoids the patient by the misery of repeated localised puncture, but uses normal saline and the equal effect of heparin sodium undesirable.
The concrete condition of normal saline and heparin sodium is as follows:
Normal saline does not have pipe sealing effect or effect extreme difference for some especial patient.For example: high blood viscosity denseness patient, hyperlipidemia patient because self-blood compares thickness, are easy to stop up the situation of remaining needle.In case the situation that remaining needle blocks appears, the remaining needle that the nurse can only more renew usually, and puncture again causes patient's the financial burden that repetition is painful and increase is new, also influences nurse's work efficiency simultaneously.And the normal saline using dosage is big, easy dilute blood, and every index is on the low side when causing blood test, and in addition because the characteristics of normal saline make too early the condensing of blood easily, blood preparation can't carry out clinical blood count after solidifying and going bad.
Though heparin sodium has anticoagulation preferably, can remedy normal saline is applied on the especial patient, but heparin sodium has shortcoming of itself and very important limitation, shortcoming is an anticoagulant, shortcoming such as easily cause bleeding, dosage is difficult for grasp, thus for have, the patient of disturbances of blood coagulation, Ying Shenyong, in order to avoid increase the weight of the state of an illness, adverse consequences appears; Limitation shows as with the blood that contains heparin sodium can't detect hematology's routine, whole blood test, hemorheology test, the experiment of projects such as serum biochemistry, pharmacokinetic experiment, serum biochemistry, blood bank's test, blood sugar test, erythrocyte sedimentation rate experiment fast, so the blood drawing of need puncturing again from other positions of patient when generally needing check above-mentioned project.In sum, as seen some especial patient promptly is not suitable for normal saline, also is not suitable for the heparin sodium tube sealing, but tube-sealing solution hirudin diluent provided by the invention just can solve the disadvantage of above-mentioned two kinds of traditional tube-sealing solutions.
The People's Republic of China's " Chinese pharmacopoeia version in 2010, first record " Hirudo (HIRUDO) ", this product is the dry all of Hirudinidae animal whitmania Whitmania pigra Whitman, Hirudo Hirudo nipponica Whitman or Folium Salicis Babylonicae Hirudo Whitmania wranulata Whitman, summer, Qiu Erji catch, scald extremely with boiling water, dry or the low humidity drying.Concoct: Hirudo is cleaned, cutting, drying.Scald Hirudo: get water purification trematodiasis section, water to little with Pulvis Talci according to the method for scalding and heave.Function with cure mainly: removing blood stasis, removing blood stasis stimulates the menstrual flow.Be used for the blood stasis amenorrhea, injury from falling down.Foreign medical science blood transfusion and 1993 the 16th volumes of blood fascicle the 6th phase record Chinese Academy of Medical Sciences Blood Research Institute, Guo Juan summary Wang Hebi examines and revises " progress of lepirudin 023 ludon " Haycraft and found in the Hementaria officianalis extract anticoagulant substances is arranged in 1884.At the end of the fifties, Markwardt isolates pure product first, called after hirudin (Hirudin), and know that it is the special inhibitor of thrombin, be a kind of ideal anticoagulant, antithrombotic preparation.Learn its structure and amino acid sequence the beginning of the eighties.Loaded down with trivial details because of the natural hirudin extraction step, and raise the Hirudo difficulty, the Hirudo source is deficient, is difficult to obtain the pure product of q.s, and research and clinical practice are restricted.In recent years, the development of technique for gene engineering has remedied this defective, utilize chemosynthesis, cDNA library, PCR method to obtain gene clone, express and obtain lepirudin 023 ludon, thereby pharmacology, pharmacodynamics and the toxicity etc. of hirudin have more in depth been studied, a large amount of zooperies and clinic trial have been accelerated hirudin and have been applied to clinical process.
The structure of hirudin: natural hirudin is not contain polysaccharide, by the single chain protein that 65 or 66 amino acid residues are formed, and molecular weight about 7,000, be rich in dicarboxylic amino acid, no Arg, Met and Trp, there are three intramolecular disulfide bonds to be positioned at peptide chain N-end, molecular configuration is played Stabilization; The C-end has more acidic amino acid residue, and a sulphation Tyr is arranged; The peptide chain middle part is by a special construction of being made up of Pro-Lys47-Pro, and it plays a part certain in hirudin and thrombin interaction.
In 11 kinds of variants of hirudin, only variant I, II and III have anticoagulating active.
So far, all can obtain active lepirudin 023 ludon through escherichia coli or Yeast system expression, and be desulfurization acidic group hirudin, promptly 63 Tyr do not have sulphation.Reorganization has isomorphic map mutually with natural prodcuts.Further can produce multiple variant.
Along with the molecular biology develop rapidly, external at present existing tens companies develop lepirudin 023 ludon and the plain preparation of functional Hirudo, a large number of experiments show that recombinant products is similar to natural prodcuts, are effective anticoagulant and antithrombotic preparation.
The clinical indication of lepirudin 023 ludon can be summarized as follows: 1) surgery anticoagulant; 2) internal medicine anticoagulant; 3) adjuvant of thrombolytic drug; 4) anticoagulant of angioplasty; 5) anticoagulant etc. in the hemodialysis.On the experimentation basis, carrying out clinical bulge test (as subacute and chronic DIC) at present.
The architectural feature of hirudin:
The single chain protein that natural hirudin is made up of 65 amino acid residues, the about 7000D of molecular weight is rich in dicarboxylic amino acid, no Arg, Met, Trp, peptide chain N-end has 3 intramolecular disulfide bond (Cys6-Cys14; Cys16-Cys28; Cys22-Cys39), molecular configuration is played Stabilization.The C-end has more acidic amino acid residue, and a sulphation Tyr is arranged, and is worked in the interaction of hirudin and thrombin by the special construction that a Pro-Lys47-Pro forms in the peptide chain middle part.
Hirudin on sale at present in market.
The utility model content
This utility model is to provide a kind of tube sealing effect that can guarantee in order to solve the variety of issue that exists in the prior art, can not need nurse's clinical manipulation easily to reach the pipe sealing purpose of malleation, need not the use amount that the nurse calculates tube-sealing solution, need not to screen patient's special circumstances selection tube-sealing solution, need not to prepare tube-sealing solution, need not the calparine cap of sterilizing before the use, can not enter blood, reduce the nurse job amount because of the calparine cap quality problems cause the medical grade rubber microgranule.Simple and safe operation, can also reduce patient's phlebitis risk, reduce malpractice, reduce doctor-patient dispute, stop because the improper need of tube sealing are changed the expense of remaining needle again, also have tube sealing time length and can artificially control the tube sealing time, do not influence the venous detaining needle external member with pipe sealing device of blood parameters again.
The technical scheme that this utility model is taked for the technical problem that exists in the solution known technology is:
Venous detaining needle external member with pipe sealing device of the present utility model comprises by the puncture needle guiding penetrating intravenous sleeve pipe, is connected the transparent threeway and the infusion connector that is used to be connected infusion pipeline or blood sampling pipeline of the built-in isolating seal plug of sleeve pipe rear end; Transparent threeway is connected with infusion connector by prolonging pipe, and infusion connector is by the sealing end caps; Transparent threeway forms the two-chamber joint with the end that the prolongation pipe is connected, and an end of two-chamber joint connects to prolong manages, and the other end connects pipe sealing device; Pipe sealing device comprises and is arranged on the liquid storing bag in the support and is arranged on the roller that between the support two side liquid in the liquid storing bag is promoted forward.
Described pipe sealing device is connected with the two-chamber joint by connection tube; The two-chamber joint with prolong a end that pipe is connected with is connected with connection tube one hold capable setting level with both hands.
The rear end of described connection tube forms the connecting portion that connects pipe sealing device, and the insertion section of pipe sealing device front end is connected in the connecting portion, and the rear end, insertion section is connected with liquid storing bag, and the inner cavity that forms in insertion section makes liquid storing bag and connection tube internal communication.
The compartment of terrain, wall upper end, the left and right sides of described support forms inclined-plane and depression, and the wheel shaft that roller central authorities are provided with is connected in the depression and along the inclined-plane and rolls forward.
The front end of described liquid storing bag stretches out from the front side wall of support, connects the insertion section; Stretch out from the rear wall of support the rear end of liquid storing bag, and the rear end is by the end cap sealing with sealing function.
The tube-sealing solution of splendid attire is the hirudin diluent in the described liquid storing bag.
Described sleeve pipe adopts four polyvinyl fluoride materials to make, and transparent threeway adopts medical material polythene material to make with the infusion connector that is used to be connected infusion pipeline or take a blood sample pipeline.
Advantage and the good effect that the utlity model has are:
Venous detaining needle external member with pipe sealing device of the present utility model is with pipe sealing device again on the venous detaining needle, need not to use in addition syringe, has saved resource, has made things convenient for nurse and patient's use simultaneously.Distance between per two depressions can guarantee that through calculating tube-sealing solution is full of the tube chamber of remaining needle, avoids backflow of blood and the blood coagulation plugging.Anticoagulant in the pipe sealing device is selected the hirudin diluent for use, compares with other tube-sealing solution, and hirudin has good anticoagulation, and is because dosage is small, without any side effects to human body.Pass through the careful required tube-sealing solution of calculating in addition and can guarantee that the hirudin diluent is full of need tube sealing place accurately, easily reach the pipe sealing effect of malleation, when the blood sampling check, can not influence the detection of anticoagulin in the blood again, suit repeatedly be used for tube sealing in discontinuity transfusion and the blood collection procedure.And the clinical manipulation that does not need the nurse easily reaches the pipe sealing purpose of malleation, need not the use amount that the nurse calculates tube-sealing solution, need not to screen patient's special circumstances selection tube-sealing solution, need not to prepare tube-sealing solution, need not the calparine cap of sterilizing before the use, can not enter blood, reduce the nurse job amount because of the calparine cap quality problems cause the medical grade rubber microgranule.Simple and safe operation can also reduce patient's phlebitis risk, reduces malpractice, reduces doctor-patient dispute, stops because the improper need of tube sealing are changed the expense of remaining needle again, also has tube sealing time length and can artificially control the tube sealing time.
Description of drawings
Fig. 1 is the structural representation with venous detaining needle external member of pipe sealing device of the present utility model.
Critical piece symbol description in the accompanying drawing:
1: sleeve pipe 2: transparent threeway 3: isolating seal plug
4: prolong pipe 5: liquid stopping block 6: infusion connector
7: the first sealing end caps sealing in 8: the second end cap 9: connection tube
10: connecting portion 11: depression 12: inclined-plane
13: roller 14: wheel shaft 15: end cap
16: liquid storing bag 17: puncture needle 18: the puncture needle handle
19: hold needle handle 20: pipe sealing device 21: union joint
22: support 23: the two-chamber joint
The specific embodiment
Followingly this utility model is described in detail with reference to drawings and Examples.Parts same as the prior art have used identical symbol in this utility model.
Fig. 1 is the structural representation with venous detaining needle external member of pipe sealing device of the present utility model.As shown in Figure 1, venous detaining needle external member with pipe sealing device of the present utility model, comprise by puncture needle 17 guiding penetrating intravenous sleeve pipe 1, be connected the transparent threeway 2 and the infusion connector 6 that is used to be connected infusion pipeline or blood sampling pipeline of the built-in isolating seal plug 3 of sleeve pipe 1 rear end.
One end of transparent threeway 2 is connected with sleeve pipe 1, and an end is sealed by isolating seal plug 3, and the 3rd end is connected with infusion connector 6 by prolonging pipe 4.Sleeve pipe 1 is socketed in outside the puncture needle 17, and stretch out from the front end of sleeve pipe 1 at the tip of puncture needle 17.The rear end of puncture needle 17 is provided with puncture needle handle 18, after sleeve pipe 1 enters vein for convenience, puncture needle 17 is extracted, and a side of puncture needle handle 18 is provided with holds needle handle 19.
Infusion connector 6 can adopt single lumen catheter, also can adopt double lumen tube.If the employing single lumen catheter, the free end of single lumen catheter is by the sealing end caps; If the employing double lumen tube, two kinds of different medicines of infusion simultaneously, the two ends of double lumen tube are respectively by the first sealing end cap 7 and second sealing end cap 8 (the being commonly called as calparine cap) sealing.
Transparent threeway 2 forms two-chamber joints 23 with the ends that prolongation pipe 4 is connected, and an end of two-chamber joint 23 connects to prolong manages 4, and the other end connects the connection tube 9 that is communicated with pipe sealing device 20.Two-chamber joint 23 with prolong pipe 4 ends that are connected with is connected with connection tube 9 one hold capable setting level with both hands.The front end that prolongs pipe 4 and connection tube 9 is provided with a liquid stopping block 5 jointly.The rear end of connection tube 9 forms the connecting portion 10 that is connected with pipe sealing device 20.Pipe sealing device 20 comprises and is arranged on the liquid storing bag 16 in the support 22 and is arranged on the roller 13 that between support 22 two sides liquid in the liquid storing bag is promoted forward.The insertion section 21 of pipe sealing device 20 front ends is connected in the connecting portion 10, and 21 rear ends, insertion section are connected with liquid storing bag 16, and the insertion section 21 inner cavitys that form make liquid storing bag 16 and connection tube 9 internal communication.
The compartment of terrain, wall upper end, the left and right sides of support 22 forms inclined-plane 12 and caves in 11, and the wheel shafts 14 that roller 13 central authorities are provided with are connected in the depression 11 and 12 rollings forward along the inclined-plane.The front end of liquid storing bag 16 stretches out from the front side wall of support 22, connects insertion section 21; Stretch out from the rear wall of support 22 rear end of liquid storing bag 16, and the rear end is by end cap 15 sealings with sealing function.
The tube-sealing solution of splendid attire is the hirudin diluent in the above-mentioned liquid storing bag 16.The concentration of hirudin is 0.01mg/ml-50mg/ml in the hirudin diluent.Use according to the about 1ml-15ml of different needs at every turn.The concentration of hirudin can be selected 0.1mg/ml, 1mg/ml, 3mg/ml or 8mg/ml for use as required.
The relation of hirudin and thrombin is as follows:
The first, lepirudin 023 ludon and α-thrombin with etc. mole non-covalent combine form stabilized complex (its dissociation constant is very little, 0.8 * 10
-10Mol or 2.0 * 10
-14Mol).The whole protease hydrolysis functions of thrombin this moment are closed, so hirudin can not only prevent fibrinogenic consolidation, and the hemostasis that can block catalyzed by thrombin is reacted, the platelet response that brings out such as activation and the thrombin of factor V, VIII and III, the thrombin that has prevented the activatory feedback of thrombinogen and caused generates, hirudin does not disturb the biosynthesis of thrombin simultaneously, and (AT-III) also do not have influence to Antithrombin III.
The second, oxidized when hirudin, disulfide bond, or its C-end is shown that by depsipeptides (the C-end reduces by 7 or 22 aminoacid then to the inhibition loss of activity 90% or 100% of thrombin) hirudin is a reversibility to the inhibitory action of thrombin.
Hirudin has following characteristics in actual applications:
The first, the agent of gene recombinaton hirudin anticoagulant does not contain heavy metal ion, does not have Sulfated pure biological preparation, and is noiseless to test item, is applicable to detections such as biochemistry, immunology, hematology.Also be applicable to unit blood specimen collections such as medical research mechanism, blood station, health and epidemic prevention.
The second, the Tyr peptide chain structure of hirudin can suppress the thrombin specificity, but this effect is reversible, and when the reaction of Tyr peptide chain warp depsipeptides, after the hirudin forfeiture suppressed activity, blood preparation also can be done hemagglutination test again.
The 3rd, haemachrome hematocrit and leukocyte etc. all there are not influence, can not only be used for the research of Physiological Experiment and clotting mechanism, and on clinical medicine, also can be used as the anticoagulant when transfusing blood.
The 4th, can reduce surface activity of blood platelet to platelet, anticoagulant reduces platelet adhesion.Hirudin can suppress the adhesive attraction of platelet to silication glass, and this is not direct interaction to hematoblastic effect, and it does not disturb hematoblastic function.
The 5th, the blood coagulation resisting function of hirudin in different animals and blood plasma its anticoagulation that confirms different with heparin, it does not rely on anticoagulant factor, does not disturb the detection of anticoagulant factor yet, is not subjected to influence of platelet CA++ (PF4) and rich histidine protein or the like yet.It is the safest, the most effective natural antithrombase anticoagulant in the known anticoagulative substance in the present world.
Claims (7)
1. venous detaining needle external member with pipe sealing device, comprise by puncture needle (17) guiding penetrating intravenous sleeve pipe (1), be connected the transparent threeway (2) and the infusion connector (6) that is used to be connected infusion pipeline or blood sampling pipeline of the built-in isolating seal plug (3) of sleeve pipe rear end; Transparent threeway (2) is connected with infusion connector (6) by prolonging pipe (4), and infusion connector is by the sealing end caps; It is characterized in that: the end that transparent threeway (2) is connected with prolongation pipe (4) forms two-chamber joint (23), and an end of two-chamber joint connects to prolong manages (4), and the other end connects pipe sealing device (20); Pipe sealing device (20) comprises and is arranged on the liquid storing bag (16) in the support (22) and is arranged on the roller (13) that liquid between support (20) two side that liquid storing bag (16) is interior promotes forward.
2. the venous detaining needle external member with pipe sealing device according to claim 1 is characterized in that: pipe sealing device (20) is connected with two-chamber joint (23) by connection tube (9); The two-chamber joint with prolong a end that pipe (4) is connected with is connected with connection tube (9) one hold capable setting level with both hands.
3. the venous detaining needle external member with pipe sealing device according to claim 2, it is characterized in that: the rear end of connection tube (9) forms the connecting portion (10) that connects pipe sealing device, the insertion section (21) of pipe sealing device (20) front end is connected in the connecting portion (10), rear end, insertion section (21) is connected with liquid storing bag (16), the inner cavity that forms in insertion section (21) makes liquid storing bag and connection tube internal communication.
4. the venous detaining needle external member with pipe sealing device according to claim 2, it is characterized in that: the compartment of terrain, left and right sides wall upper end of support (22) forms inclined-plane (12) and depression (11), the wheel shaft (14) that roller (13) central authorities are provided be connected depression (11) interior and along the inclined-plane (12) roll forward.
5. the venous detaining needle external member with pipe sealing device according to claim 2 is characterized in that: the front end of liquid storing bag (16) stretches out from the front side wall of support (22), connects insertion section (21); Stretch out from the rear wall of support (22) rear end of liquid storing bag (16), and the rear end is sealed by the end cap with sealing function (15).
6. the venous detaining needle external member with pipe sealing device according to claim 2 is characterized in that: the tube-sealing solution of the interior splendid attire of liquid storing bag (16) is the hirudin diluent.
7. the venous detaining needle external member with pipe sealing device according to claim 2, it is characterized in that: sleeve pipe (1) adopts four polyvinyl fluoride materials to make, and transparent threeway (2) adopts medical material polythene material to make with the infusion connector (6) that is used to be connected infusion pipeline or to take a blood sample pipeline.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011200243518U CN202027990U (en) | 2011-01-26 | 2011-01-26 | Venous retention needle sleeve element with pipe sealing device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011200243518U CN202027990U (en) | 2011-01-26 | 2011-01-26 | Venous retention needle sleeve element with pipe sealing device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202027990U true CN202027990U (en) | 2011-11-09 |
Family
ID=44890306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011200243518U Expired - Fee Related CN202027990U (en) | 2011-01-26 | 2011-01-26 | Venous retention needle sleeve element with pipe sealing device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202027990U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104399145A (en) * | 2014-12-18 | 2015-03-11 | 邓杜娟 | Double-cavity-catheter self-sealing venous indwelling needle |
| CN107485757A (en) * | 2017-08-16 | 2017-12-19 | 裴泽军 | Novel remaining needle |
-
2011
- 2011-01-26 CN CN2011200243518U patent/CN202027990U/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104399145A (en) * | 2014-12-18 | 2015-03-11 | 邓杜娟 | Double-cavity-catheter self-sealing venous indwelling needle |
| CN104399145B (en) * | 2014-12-18 | 2016-11-23 | 邓杜娟 | A kind of double lumen tube self-sealing venous detaining needle |
| CN107485757A (en) * | 2017-08-16 | 2017-12-19 | 裴泽军 | Novel remaining needle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068731B (en) | Venous retention needle suite with hirudin anticoagulation tube sealing device | |
| CN202185013U (en) | Anti-coagulation sealing tube suite | |
| CN202028026U (en) | Venous remaining needle with pipe sealing device | |
| CN102068730B (en) | Hirudin anticoagulation seal tube kit for vein detained needle | |
| CN101695446B (en) | Disposable soft connecting band collection container and anti-freezing vacuum blood taking needle of bleeding opening | |
| JP2703582B2 (en) | Dialysis machine | |
| CN202027990U (en) | Venous retention needle sleeve element with pipe sealing device | |
| CN202376556U (en) | Anticoagulant tube sealer for vein remaining needle | |
| CN201939797U (en) | Pipe-sealing device for intravenous indwelling needle | |
| CN101695447B (en) | Disposable hard connecting band collection container and anti-freezing vacuum blood taking needle of bleeding opening | |
| CN102119861B (en) | Venous indwelling needle with hirudin anticoagulation pipe-sealing device | |
| CN102488939A (en) | Anticoagulation pipe sealing device of venous indwelling needle | |
| CN201996922U (en) | Intravenous indwelling needle tube sealing assembly | |
| CN102120051B (en) | Hirudin anticoagulation tube sealing device for venous retention needle | |
| CN201631207U (en) | Disposable hard-connected parallel multi-tube anticoagulant vacuum blood sampling matched set | |
| CN201516035U (en) | Anti-coagulation vacuum blood collecting needle of disposable soft tape splicing collecting container | |
| CN201519153U (en) | Disposable hard-wired type anti-coagulation blood taking needle | |
| CN101785677B (en) | Disposable hard connection hirudin anti-coagulation transverse vacuum blood collection kit | |
| Harenberg et al. | Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay | |
| CN201524083U (en) | Disposable flexibly connected anticoagulant blood taking needle | |
| CN201516036U (en) | Anti-coagulation blood collecting needle of disposable soft tape splicing collecting container and blood discharge hole | |
| CN101785676B (en) | Disposable flexible connection hirudin anti-coagulation transverse vacuum blood collection kit | |
| CN205339731U (en) | Interior liquid bag of needle file is proclaimed oneself formula vein and is kept somewhere needle | |
| CN201516037U (en) | Anti-coagulation vacuum blood collecting needle of disposable hard tape splicing collecting container | |
| CN201516034U (en) | Anti-coagulation vacuum blood collecting needle of disposable hard connecting belt blood specimen collecting container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20160817 Granted publication date: 20111109 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20170607 Granted publication date: 20111109 |
|
| PD01 | Discharge of preservation of patent | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111109 Termination date: 20180126 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |